Fundraising Fox
Broadwing
South San Francisco, US · 3 employees on LinkedIn · 1 known investors
Find your way into Broadwing
Sign up to find every way you can get introduced to Broadwing
- Your email: who you already know at Broadwing, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Broadwing team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Broadwing Bio develops antibody-based therapies targeting genetically validated ophthalmology conditions, particularly geographic atrophy and glaucoma, to preserve vision and prevent blindness. The company builds on naturally occurring genetic variants to create novel treatments for ocular diseases.
Founders & leadership
AP
Andrew Peterson, Ph.D.Founder, CEO and board member
JC
Jennifer Cygan, Ph.D.Founder
MR
Manuel Rivas, D.PhilFounder and scientific advisory board member
Investors · 1
82VSlisted by 82VSBoston
How we know: 82VS's portfolio page · Not right? Tell us
Frequently asked questions
- What does Broadwing do?
- Broadwing Bio develops antibody-based therapies targeting genetically validated ophthalmology conditions, particularly geographic atrophy and glaucoma, to preserve vision and prevent blindness. The company builds on naturally occurring genetic variants to create novel treatments for ocular diseases.
- Who founded Broadwing?
- Broadwing was founded by Andrew Peterson, Ph.D., Jennifer Cygan, Ph.D., Manuel Rivas, D.Phil.
- Who are Broadwing's investors?
- Broadwing's investors include 82VS.
- Where is Broadwing headquartered?
- Broadwing is headquartered in South San Francisco, US.